Comparison of the efficacy and safety of tolterodine 2 mg and 4 mg combined with an α-blocker in men with lower urinary tract symptoms (LUTS) and overactive bladder: a randomized controlled trial
2015 ◽
Vol 5
(3)
◽
pp. 312-318
2011 ◽
Vol 81
(4)
◽
pp. e385-e392
◽
2005 ◽
Vol 16
(4)
◽
pp. 257-262
◽
2014 ◽
Vol 191
(4)
◽
pp. 1040-1044
◽
2004 ◽
Vol 191
(1)
◽
pp. 73-82
◽